Trial Profile
A Comparison of Safety and Efficacy of Dl-3-n-butylphthalide and Cerebrolysin on Neurological and Behavioral Outcomes in Acute Ischemic Stroke: a Randomized, Double-blind Study.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Aug 2020
Price :
$35
*
At a glance
- Drugs Butylphthalide (Primary) ; FPF 1070 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 04 Jul 2014 New trial record